These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Novel, highly potent aldose reductase inhibitors: (R)-(-)-2-(4-bromo-2-fluorobenzyl)-1,2,3,4- tetrahydropyrrolo[1,2-a]pyrazine -4-spiro-3'-pyrrolidine-1,2',3,5'-tetrone (AS-3201) and its congeners. Negoro T; Murata M; Ueda S; Fujitani B; Ono Y; Kuromiya A; Komiya M; Suzuki K; Matsumoto J J Med Chem; 1998 Oct; 41(21):4118-29. PubMed ID: 9767647 [TBL] [Abstract][Full Text] [Related]
13. Acid derivatives of benzisothiazole-1,1-dioxide as inhibitors of rat lens aldose reductase. Da Settimo A; Primofiore G; La Motta C; Da Settimo F; Simorini F; Boldrini E; Bianchini P Farmaco; 1996 Apr; 51(4):261-7. PubMed ID: 8645413 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of novel aldose reductase inhibitors: Effects on lens protein kinase Cgamma. Lewis S; Karrer J; Saleh S; Chan X; Tan Z; Hua D; McGill J; Pang YP; Fenwick B; Brightman A; Takemoto D Mol Vis; 2001 Jul; 7():164-71. PubMed ID: 11483892 [TBL] [Abstract][Full Text] [Related]
15. Curcumin analogs as potent aldose reductase inhibitors. Du ZY; Bao YD; Liu Z; Qiao W; Ma L; Huang ZS; Gu LQ; Chan AS Arch Pharm (Weinheim); 2006 Mar; 339(3):123-8. PubMed ID: 16528793 [TBL] [Abstract][Full Text] [Related]
16. Carboxymethylated pyridoindole antioxidants as aldose reductase inhibitors: Synthesis, activity, partitioning, and molecular modeling. Stefek M; Snirc V; Djoubissie PO; Majekova M; Demopoulos V; Rackova L; Bezakova Z; Karasu C; Carbone V; El-Kabbani O Bioorg Med Chem; 2008 May; 16(9):4908-20. PubMed ID: 18395454 [TBL] [Abstract][Full Text] [Related]
17. In vitro evaluation of 5-arylidene-2-thioxo-4-thiazolidinones active as aldose reductase inhibitors. Maccari R; Del Corso A; Giglio M; Moschini R; Mura U; Ottanà R Bioorg Med Chem Lett; 2011 Jan; 21(1):200-3. PubMed ID: 21129963 [TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of potent and selective aldose reductase inhibitors based on pyridylthiadiazine scaffold. Chen X; Yang Y; Ma B; Zhang S; He M; Gui D; Hussain S; Jing C; Zhu C; Yu Q; Liu Y Eur J Med Chem; 2011 May; 46(5):1536-44. PubMed ID: 21367494 [TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships and molecular modelling of new 5-arylidene-4-thiazolidinone derivatives as aldose reductase inhibitors and potential anti-inflammatory agents. Maccari R; Vitale RM; Ottanà R; Rocchiccioli M; Marrazzo A; Cardile V; Graziano AC; Amodeo P; Mura U; Del Corso A Eur J Med Chem; 2014 Jun; 81():1-14. PubMed ID: 24819954 [TBL] [Abstract][Full Text] [Related]
20. Novel, highly potent aldose reductase inhibitors: cyano(2-oxo-2,3-dihydroindol-3-yl)acetic acid derivatives. Da Settimo F; Primofiore G; Da Settimo A; La Motta C; Simorini F; Novellino E; Greco G; Lavecchia A; Boldrini E J Med Chem; 2003 Apr; 46(8):1419-28. PubMed ID: 12672241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]